• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植等待名单结果的竞争风险分析:两个重要的统计学视角。

Competing Risks Analysis of Kidney Transplant Waitlist Outcomes: Two Important Statistical Perspectives.

作者信息

Gaynor Jeffrey J, Guerra Giselle, Vianna Rodrigo, Tabbara Marina M, Graell Enric Lledo, Ciancio Gaetano

机构信息

Department of Surgery, Miami Transplant Institute, University of Miami Miller School of Medicine; Miami, Florida, USA.

Department of Medicine, Miami Transplant Institute, University of Miami Miller School of Medicine; Miami, Florida, USA.

出版信息

Kidney Int Rep. 2024 Feb 1;9(6):1580-1589. doi: 10.1016/j.ekir.2024.01.050. eCollection 2024 Jun.

DOI:10.1016/j.ekir.2024.01.050
PMID:38899174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11184382/
Abstract

Modern competing risks analysis has 2 primary goals in clinical epidemiology as follows: (i) to maximize the clinician's knowledge of etiologic associations existing between potential predictor variables and various cause-specific outcomes via cause-specific hazard models, and (ii) to maximize the clinician's knowledge of noteworthy differences existing in cause-specific patient risk via cause-specific subdistribution hazard models (cumulative incidence functions [CIFs]). A perfect application exists in analyzing the following 4 distinct outcomes after listing for a deceased donor kidney transplant (DDKT): (i) receiving a DDKT, (ii) receiving a living donor kidney transplant (LDKT), (iii) waitlist removal due to patient mortality or a deteriorating medical condition, and (iv) waitlist removal due to other reasons. It is important to realize that obtaining a complete understanding of subdistribution hazard ratios (HRs) is simply not possible without first having knowledge of the multivariable relationships existing between the potential predictor variables and the cause-specific hazards (perspective #1), because the cause-specific hazards form the "building blocks" of CIFs. In addition, though we believe that a worthy and practical alternative to estimating the median waiting-time-to DDKT is to ask, "what is the conditional probability of the patient receiving a DDKT, given that he or she would not previously experience one of the competing events (known as the cause-specific conditional failure probability)," only an appropriate estimator of this conditional type of cumulative incidence should be used (perspective #2). One suggested estimator, the well-known "one minus Kaplan-Meier" approach (censoring competing events), simply does not represent any probability in the presence of competing risks and will almost always produce biased estimates (thus, it should never be used).

摘要

现代竞争风险分析在临床流行病学中有以下两个主要目标

(i)通过特定病因风险模型,最大化临床医生对潜在预测变量与各种特定病因结局之间存在的病因关联的了解;(ii)通过特定病因的亚分布风险模型(累积发病率函数[CIFs]),最大化临床医生对特定病因患者风险中存在的显著差异的了解。在分析 deceased donor kidney transplant(DDKT, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant, deceased donor kidney transplant(此处原文重复,疑有误)后列出的以下4种不同结局时存在完美应用:(i)接受 deceased donor kidney transplant(DDKT),(ii)接受活体供肾移植(LDKT),(iii)因患者死亡或病情恶化而从等待名单中移除,以及(iv)因其他原因从等待名单中移除。必须认识到,如果没有首先了解潜在预测变量与特定病因风险之间存在的多变量关系(观点#1),就根本不可能完全理解亚分布风险比(HRs),因为特定病因风险构成了CIFs的“基石”。此外,尽管我们认为,估计等待 deceased donor kidney transplant(DDKT)的中位时间的一个有价值且实用的替代方法是询问“在患者先前未经历任何竞争事件的情况下,其接受 deceased donor kidney transplant(DDKT)的条件概率是多少(称为特定病因条件失败概率)”,但应仅使用这种条件类型累积发病率的适当估计器(观点#2)。一种建议估计器,即著名的“1减去Kaplan-Meier”方法(对竞争事件进行删失),在存在竞争风险的情况下根本不代表任何概率,并且几乎总是会产生有偏差的估计(因此,绝不应该使用)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06a/11184382/e4151a50ece3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06a/11184382/01787675b795/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06a/11184382/e4151a50ece3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06a/11184382/01787675b795/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06a/11184382/e4151a50ece3/gr2.jpg

相似文献

1
Competing Risks Analysis of Kidney Transplant Waitlist Outcomes: Two Important Statistical Perspectives.肾移植等待名单结果的竞争风险分析:两个重要的统计学视角。
Kidney Int Rep. 2024 Feb 1;9(6):1580-1589. doi: 10.1016/j.ekir.2024.01.050. eCollection 2024 Jun.
2
Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.ABO 不相容活体供肾移植对患者生存的影响。
Am J Kidney Dis. 2020 Nov;76(5):616-623. doi: 10.1053/j.ajkd.2020.03.029. Epub 2020 Jul 12.
3
Beyond "Median Waiting Time": Development and Validation of a Competing Risk Model to Predict Outcomes on the Kidney Transplant Waiting List.超越“中位等待时间”:一种竞争风险模型的开发与验证,用于预测肾移植等待名单上的结果
Transplantation. 2016 Jul;100(7):1564-70. doi: 10.1097/TP.0000000000001185.
4
Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.Fine-Gray 子分布风险模型可同时估计不同事件类型的绝对风险:累积总失效概率可能超过 1。
Stat Med. 2021 Aug 30;40(19):4200-4212. doi: 10.1002/sim.9023. Epub 2021 May 9.
5
Effect of pretransplant dialysis vintage on clinical outcomes in deceased donor kidney transplant.移植前透析年限对尸体供肾移植临床结局的影响。
Sci Rep. 2022 Oct 21;12(1):17614. doi: 10.1038/s41598-022-20003-2.
6
Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.在存在竞争风险和随机删失的情况下,估计两个原因特异性累积发生率函数的差异的置信区间的改进。
Biom J. 2020 Oct;62(6):1394-1407. doi: 10.1002/bimj.201900060. Epub 2020 Mar 29.
7
Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.方法:糖尿病患者终末期肾病和死亡率的竞争风险分析。
BMC Med Res Methodol. 2010 Oct 21;10:97. doi: 10.1186/1471-2288-10-97.
8
Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.存在竞争风险时的生存分析:等待肾移植候选人的实例
Am J Transplant. 2016 Jul;16(7):1958-66. doi: 10.1111/ajt.13717. Epub 2016 Mar 3.
9
Association of pathogen-specific clinical mastitis in the first 100 days of first lactation with productive lifetime: An observational study comparing competing risks models for death and sale with the Cox model.头胎泌乳期前100天病原体特异性临床乳腺炎与生产寿命的关联:一项比较死亡和出售竞争风险模型与Cox模型的观察性研究
Prev Vet Med. 2023 Apr;213:105879. doi: 10.1016/j.prevetmed.2023.105879. Epub 2023 Feb 18.
10
Analysis and design of randomised clinical trials involving competing risks endpoints.涉及竞争风险终点的随机临床试验的分析与设计。
Trials. 2011 May 19;12:127. doi: 10.1186/1745-6215-12-127.

本文引用的文献

1
Does anybody really know what (the kidney median waiting) time is?有人真的知道(肾脏中位等待)时间是多少吗?
Am J Transplant. 2023 Feb;23(2):223-231. doi: 10.1016/j.ajt.2022.12.005. Epub 2023 Jan 12.
2
A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States.美国用于预后不良的肾移植候选者接受尸体供体移植决策的一种工具。
Kidney Int. 2022 Sep;102(3):640-651. doi: 10.1016/j.kint.2022.05.025. Epub 2022 Jun 26.
3
Graft Failure Due to Nonadherence among 150 Prospectively-Followed Kidney Transplant Recipients at 18 Years Post-transplant: Our Results and Review of the Literature.
150例前瞻性随访的肾移植受者术后18年因依从性不佳导致的移植失败:我们的结果及文献综述
J Clin Med. 2022 Feb 28;11(5):1334. doi: 10.3390/jcm11051334.
4
Dramatic secular changes in prognosis for kidney transplant candidates in the United States.美国肾移植候选人预后的显著长期变化。
Am J Transplant. 2019 Feb;19(2):414-424. doi: 10.1111/ajt.15021. Epub 2018 Aug 14.
5
Practical recommendations for reporting Fine-Gray model analyses for competing risk data.关于报告竞争风险数据的Fine-Gray模型分析的实用建议。
Stat Med. 2017 Nov 30;36(27):4391-4400. doi: 10.1002/sim.7501. Epub 2017 Sep 15.
6
Beyond "Median Waiting Time": Development and Validation of a Competing Risk Model to Predict Outcomes on the Kidney Transplant Waiting List.超越“中位等待时间”:一种竞争风险模型的开发与验证,用于预测肾移植等待名单上的结果
Transplantation. 2016 Jul;100(7):1564-70. doi: 10.1097/TP.0000000000001185.
7
Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.存在竞争风险时的生存分析:等待肾移植候选人的实例
Am J Transplant. 2016 Jul;16(7):1958-66. doi: 10.1111/ajt.13717. Epub 2016 Mar 3.
8
Competing risks analyses: objectives and approaches.竞争风险分析:目标与方法
Eur Heart J. 2014 Nov 7;35(42):2936-41. doi: 10.1093/eurheartj/ehu131. Epub 2014 Apr 7.
9
Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.美国不同地理位置的西班牙裔和非西班牙裔白人在接受肾移植方面的差异。
Clin J Am Soc Nephrol. 2013 Dec;8(12):2149-57. doi: 10.2215/CJN.01560213. Epub 2013 Oct 10.
10
Competing risks in epidemiology: possibilities and pitfalls.流行病学中的竞争风险:可能性与陷阱。
Int J Epidemiol. 2012 Jun;41(3):861-70. doi: 10.1093/ije/dyr213. Epub 2012 Jan 9.